<span>Animal Health: Veterinary Vaccine Development</span>
April 29, 2025

Animal Health: Veterinary Vaccine Development

Streamline vaccine development with operational efficiency and flexible study design Veterinary vaccine development is crucial for animal health, public safety and food security by helping to prevent zoonotic diseases, reduce antibiotic use and protect livestock productivity. However, challenges like disease variations, regulatory hurdles, high costs, cold chain logistics, species-specific efficacy and public reluctance hinder widespread adoption.
<span>Extraction Vehicle Selection for the Material Mediated Pyrogen Test</span>
April 29, 2025

Extraction Vehicle Selection for the Material Mediated Pyrogen Test

Following submission of a package to a regulatory body, it is typical to receive feedback regarding some portion of the submission, including biocompatibility. Recently, Labcorp provided guidance to a client who needed help responding to a submission finding that we had previously navigated. We share both the finding and response below. Sharing common or important findings, and the responses to them, can help the community and regulators better understand the evaluation methods and ensure that future submissions are as successful as possible.
<span>Site neutrality and future-proofing the laboratory</span>
April 29, 2025

Site neutrality and future-proofing the laboratory

Bryan Vaughn, senior vice president of health systems at Labcorp, shares his perspective on site neutrality and how to future-proof the lab. For health system leaders, early 2025 has been a whirlwind of potential policy changes – from Medicaid funding to NIH grants – that could impact providers in a material, long-term manner.  Underlying and apart from policy uncertainty, 2025 could well be an inflection point for healthcare costs.  
April 28, 2025

Prenatal Testing: The Importance of Early Preeclampsia and Genetic Screening in Pregnancy

Early preeclampsia and genetic screening in pregnancy can identify conditions that may increase risk for fetal and maternal complications. Insights from these screenings can help your patients better prepare for the future.In our webinar, you'll learn how early preeclampsia screening and the latest developments in cell-free DNA (cfDNA) noninvasive prenatal testing (NIPT) can help you improve maternal and perinatal outcomes.
<span>On-Demand Webinar:  Systemic Mastocytosis - Insights Into A Rare Blood Disorder</span>
March 25, 2025

On-Demand Webinar: Systemic Mastocytosis - Insights Into A Rare Blood Disorder

Presented by guest speaker Dr. Alejandro Gru, MD, Professor of Dermatology and Director of Dermapathology at Columbia University’s Irving Medical Center, this webinar provides information about systemic mastocytosis, a rare blood disorder where abnormal mast cells (white blood cells) build up in different parts of the human body, resulting in a variety of symptoms. It is estimated that over 32,000 United States citizens could be living with this disease, and this webinar profiles what causes systemic mastocytosis, how this condition affects patients, how systemic mastocytosis can be detected and how are patients being treated for this disease.